Germantown’s Precigen Announces First Patient Dosed for PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP) GERMANTOWN, Md., March 23, 2021 /PRNewswire/ — Precigen, Inc., a biopharmaceutical company specializing in the development [….]
Rockville’s Sensei Biotherapeutics Announces $30 Million Financing to Advance Clinical Pipeline of Oncology Therapeutics and Proprietary ImmunoPhage™ Platform
Published on :– Round co-led by Apeiron Investment Group and Catalio Capital Management – Proceeds support advancement of lead product candidate and next-generation platform for personalized yet off-the-shelf cancer immunotherapies BOSTON & [….]
Nick Fullenkamp Appointed Chief Business Officer at Avidea Technologies, Inc.
Published on :Nick Fullenkamp Appointed Chief Business Officer at Avidea Technologies, Inc. Nick Fullenkamp, M.B.A. has joined Avidea Technologies as Chief Business Officer and will be leading Business Development, financing strategy and [….]
Weekly Roundup of COVID-19 Progress From T-Cell to Microbiome Therapies and FDA Emergency Use Applications
Published on :Weekly Roundup of COVID-19 Progress From T-Cell to Microbiome Therapies and FDA Emergency Use Applications April 21, 2020 Organizations from across the BioHealth Capital Region (BCHR) continue to pivot research, [….]
Leidos’s New Virtual Biotech Startup ‘ExGloH’ Targets Cancer and Infectious Diseases with Improved T Cell Therapies
Published on :Leidos’s New Virtual Biotech Startup ‘ExGloH’ Targets Cancer and Infectious Diseases with Improved T Cell Therapies Leidos’s ExGloH Leverages Entrepreneurial Science and Industry-Leading Support Infrastructure to Improve Global Health June [….]
NextCure files for $92M IPO to advance Cancer Immunotherapy Pipeline
Published on :NextCure files for $92M IPO to advance Cancer Immunotherapy Pipeline April 29, 2019 NextCure, a clinical-stage biotech in Beltsville, MD developing cancer immunotherapies, announced the terms for its IPO that [….]
4 Vaccine and Immunotherapy Companies in Maryland That Are Redefining the Capabilities of Modern Medicine
Published on :4 Vaccine and Immunotherapy Companies in Maryland That Are Redefining the Capabilities of Modern Medicine Maryland’s World Leading Vaccine Hub Showcased at Fourth Annual MTC Life Science Breakfast January 22, [….]
New Technology Impacting Immune-Oncology Research Attracts National Audience at First Annual Bio-Trac Symposium
Published on :Immune-Oncology Symposium
Q&A with Immunomic’s Teri Heiland, PhD: What the ‘UNITE’ Technology Platform Could Mean for the Future of Immunotherapy
Published on :Q&A with Immunomic’s Teri Heiland, PhD What the ‘UNITE’ Technology Platform Could Mean for the Future of Immunotherapy September 25, 2018 Teri Heiland, Ph.D. is the Senior Vice President [….]